Rahul Sharma

CSO

Rahul has co-founder and CSO of Scienetix, a company dedicated to enabling Molecular Diagnosis. Dr. Sharma is a board-certified laboratory director and technical lead for Next Generation Sequencing (NGS) and PCR-based assay development and clinical testing. He has developed multiple Molecular Diagnosis tests and translated them into clinical testing.

Former to joining the for-profit biotech industry, he has served as Head of the Department of Molecular Biology at the National Hansen's Disease (Leprosy) Program (NHDP) under the U.S. Department of Health and Human Services (HHS), where he established an NGS facility and a Molecular Pathology Laboratory for providing early diagnosis to leprosy patients from across the country. This clinical lab is the only laboratory in the country of its kind. His research findings are being used by national agencies (DHH, CDC) to issue recommendations in the field of leprosy. Dr. Sharma has authored more than thirty publications and filed 3 patents. His research findings are being used by national agencies (DHH, CDC) to issue recommendations in the field of leprosy. He obtained his Ph.D. from Indian Council for Medical Research (ICMR) with a research focus on Microbial Genomics.